Cost‐effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial-Reference-Cited by-同舟云学术

Cost‐effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial

Published:2021-04-02 Issue:9 Volume:10 Page:2996-3003
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Cromwell Ian¹²³,Smith Laurie W.²^ORCID,Hoek Kim¹²,Hedden Lindsay⁴⁵^ORCID,Coldman Andrew J.²,Cook Darrel⁶^ORCID,Franco Eduardo L.⁷,Krajden Mel⁶,Martin Ruth⁸,Lee Marette H.⁸⁹^ORCID,Stuart Gavin¹⁰,Niekerk Dirk⁸,Ogilvie Gina⁶¹⁰¹¹,Peacock Stuart¹²⁴^ORCID

Affiliation:

1. Canadian Centre for Applied Research in Cancer ControlBC Cancer Research Institute Vancouver BC Canada

2. British Columbia Cancer AgencyCancer Control ResearchBC Cancer Research Institute Vancouver BC Canada

3. Canadian Agency for Drugs and Technologies in Health Ottawa ON Canada

4. Faculty of Health Sciences Simon Fraser University Burnaby BC Canada

5. BC Academic Health Sciences Network Vancouver BC Canada

6. British Columbia Centre for Disease Control Vancouver BC Canada

7. Division of Cancer Epidemiology McGill University Montreal QC Canada

8. British Columbia Cancer AgencyCervical Cancer Screening Program Vancouver BC Canada

9. Vancouver General HospitalGynecologic Oncology Vancouver BC Canada

10. Faculty of Medicine The University of British Columbia Vancouver BC Canada

11. Women’s Health Research InstituteBC Women’s Hospital Vancouver BC Canada

Funder

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3864

Reference36 articles.

1. Canadian Cancer Society's Advisory Committee on Cancer Statistics.Canadian cancer statistics 2017.2017;cancer.ca/Canadian‐CancerStatistics‐2017‐EN.pdf

2. Screening for cervical cancer: a systematic review and meta-analysis

3. BC Provincial Colposcopy Program.Management algorithms for abnormal cervical cytology and colposcopy.2015; Management Algorithms for Abnormal Cervical Cytology and Colposcopy. Accessed April 11 2018.

4. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Capillary-driven microfluidic device integrating recombinase polymerase amplification for human papillomavirus detection;Sensors and Actuators B: Chemical;2024-02

2. High risk HPV testing for cervical cancer screening in a Puerto Rican population;Gynecologic Oncology Reports;2023-08

3. Clinical efficacy of primary human papillomavirus (HPV) screening with partial genotyping for HPV-16 and HPV-18 subtypes in women from 25 years old;Annals of the Academy of Medicine, Singapore;2023-05-30

4. A New Brazilian Device for Cervical Cancer Screening: Acceptability and Accuracy of Self-sampling;Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics;2023-05

5. Patient Preferences in Targeted Pharmacotherapy for Cancers: A Systematic Review of Discrete Choice Experiments;PharmacoEconomics;2022-11-14